Talcid

PreclinicalSmall molecule

Bayer

Talcid is one of 8 small molecule programs targeting Gastritis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GastritisActive, not recruiting

GastritisPreclinical

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Gastritis

#DrugCompanyPhaseTrials

Prevacid

Takeda

Approved

1 2

Nexium

DDexcel Pharma Technologies Ltd.

Approved

2 3

Prilosec

DDexcel Pharma Technologies Ltd.

Approved

2 4

Takecab

PPhathom Pharmaceuticals, Inc.

Approved

1 5

Amoxil

GGlobal Antibiotics Research and Development Partnership

Entyvio

1 7

Mononuclear Cells

NNational University of Malaysia

Preclinical

1 8

Talcid

Bayer

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Efficacy and Safety1 trial

Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn Episodes

Completed· Bayer logo

Bayer·Phase 4·NCT01928888·559 enrolled

Gastritis1 trial

The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis

Completed·WWangjing Hospital, China Academy of Chinese Medical Sciences·N/A·NCT02955134·468 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Talcid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Talcid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Talcid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Bayer

Talcid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Efficacy and Safety1 trial

Gastritis1 trial

References

Drug Info

Quick Facts

Related News